Anesthetic Effect-Pipeline Review, H1 2017

Anesthetic Effect-Pipeline Review, H1 2017


  • Products Id :- GMDHC9165IDB
  • |
  • Pages: 85
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Anesthetic Effect-Pipeline Review, H1 2017

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Anesthetic Effect-Pipeline Review, H1 2017, provides an overview of the Anesthetic Effect (Central Nervous System) pipeline landscape.

Anesthetic effect causes a loss of consciousness. The factors that can increase risk of complications include smoking, obstructive sleep apnea, obesity, high blood pressure, history of adverse reactions to anesthesia and drug allergies.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Anesthetic Effect-Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Anesthetic Effect (Central Nervous System), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Anesthetic Effect (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Anesthetic Effect and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, Preclinical, Discovery and Unknown stages are 3, 2, 1, 3, 15, 1 and 1 respectively. Similarly, the Universities portfolio in Preclinical stages comprises 1 molecules, respectively.

Anesthetic Effect (Central Nervous System) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

The pipeline guide provides a snapshot of the global therapeutic landscape of Anesthetic Effect (Central Nervous System).

The pipeline guide reviews pipeline therapeutics for Anesthetic Effect (Central Nervous System) by companies and universities/research institutes based on information derived from company and industry-specific sources.

The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.

The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

The pipeline guide reviews key companies involved in Anesthetic Effect (Central Nervous System) therapeutics and enlists all their major and minor projects.

The pipeline guide evaluates Anesthetic Effect (Central Nervous System) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

The pipeline guide encapsulates all the dormant and discontinued pipeline projects.

The pipeline guide reviews latest news related to pipeline therapeutics for Anesthetic Effect (Central Nervous System)

Reasons to Buy

Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.

Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.

Find and recognize significant and varied types of therapeutics under development for Anesthetic Effect (Central Nervous System).

Classify potential new clients or partners in the target demographic.

Develop tactical initiatives by understanding the focus areas of leading companies.

Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.

Formulate corrective measures for pipeline projects by understanding Anesthetic Effect (Central Nervous System) pipeline depth and focus of Indication therapeutics.

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.

Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Introduction 5

Global Markets Direct Report Coverage 5

Anesthetic Effect-Overview 6

Anesthetic Effect-Therapeutics Development 7

Pipeline Overview 7

Pipeline by Companies 8

Pipeline by Universities/Institutes 10

Products under Development by Companies 11

Products under Development by Universities/Institutes 13

Anesthetic Effect-Therapeutics Assessment 14

Assessment by Target 14

Assessment by Mechanism of Action 16

Assessment by Route of Administration 18

Assessment by Molecule Type 20

Anesthetic Effect-Companies Involved in Therapeutics Development 21

4P Therapeutics LLC 21

Biolab Farmaceutica Ltda 21

Drawbridge Pharmaceuticals Pty Ltd 22

Expanesthetics Inc 22

Jiangsu Hengrui Medicine Co Ltd 23

Lee's Pharmaceutical Holdings Ltd 23

Lipicard Technologies Ltd 24

NanoMedex Pharmaceuticals Inc 24

Paion AG 25

Phosphagenics Ltd 25

Physica Pharma 26

Primex Pharmaceuticals Oy 26

Proteus SA 27

Sphaera Pharma Pvt Ltd 27

Taiwan Liposome Company Ltd 28

The Medicines Company 29

WEX Pharmaceuticals Inc 29

Anesthetic Effect-Drug Profiles 30

alphaxalone-Drug Profile 30

bupivacaine hydrochloride SR-Drug Profile 32

Carboetomidate-Drug Profile 33

gabafol-Drug Profile 34

HSK-3486-Drug Profile 35

lidocaine hydrochloride-Drug Profile 36

lidocaine hydrochloride-Drug Profile 37

LT-1121-Drug Profile 38

LT-1123-Drug Profile 39

MDCO-700-Drug Profile 40

Methoxycarbonyl Carboetomidate-Drug Profile 42

Methoxycarbonyl Etomidate-Drug Profile 43

midazolam hydrochloride-Drug Profile 45

neosaxitoxin-Drug Profile 46

PB-5109-Drug Profile 48

PHY-301-Drug Profile 49

propofol-Drug Profile 50

propofol-Drug Profile 51

propofol-Drug Profile 52

remimazolam-Drug Profile 53

remimazolam-Drug Profile 60

Small Molecule for General Anesthetic Effect-Drug Profile 61

Small Molecules for General Anesthetic Effect-Drug Profile 62

Small Molecules to Inhibit NMDA Receptor for Anesthesia-Drug Profile 63

SPR-819-Drug Profile 64

Tetrodotoxin-Drug Profile 65

TLC-590-Drug Profile 67

Anesthetic Effect-Dormant Projects 68

Anesthetic Effect-Discontinued Products 69

Anesthetic Effect-Product Development Milestones 70

Featured News & Press Releases 70

Appendix 82

Methodology 82

Coverage 82

Secondary Research 82

Primary Research 82

Expert Panel Validation 82

Contact Us 82

Disclaimer 83

List of Figures

Number of Products under Development for Anesthetic Effect, H1 2017

Number of Products under Development by Companies, H1 2017

Number of Products by Top 10 Targets, H1 2017

Number of Products by Stage and Top 10 Targets, H1 2017

Number of Products by Top 10 Mechanism of Actions, H1 2017

Number of Products by Stage and Top 10 Mechanism of Actions, H1 2017

Number of Products by Routes of Administration, H1 2017

Number of Products by Stage and Routes of Administration, H1 2017

Number of Products by Stage and Molecule Types, H1 2017

List of Tables

Number of Products under Development for Anesthetic Effect, H1 2017

Number of Products under Development by Companies, H1 2017

Number of Products under Development by Universities/Institutes, H1 2017

Products under Development by Companies, H1 2017

Products under Development by Companies, H1 2017 (Contd..1), H1 2017

Products under Development by Universities/Institutes, H1 2017

Number of Products by Stage and Target, H1 2017

Number of Products by Stage and Mechanism of Action, H1 2017

Number of Products by Stage and Route of Administration, H1 2017

Number of Products by Stage and Molecule Type, H1 2017

Anesthetic Effect-Pipeline by 4P Therapeutics LLC, H1 2017

Anesthetic Effect-Pipeline by Biolab Farmaceutica Ltda, H1 2017

Anesthetic Effect-Pipeline by Drawbridge Pharmaceuticals Pty Ltd, H1 2017

Anesthetic Effect-Pipeline by Expanesthetics Inc, H1 2017

Anesthetic Effect-Pipeline by Jiangsu Hengrui Medicine Co Ltd, H1 2017

Anesthetic Effect-Pipeline by Lee's Pharmaceutical Holdings Ltd, H1 2017

Anesthetic Effect-Pipeline by Lipicard Technologies Ltd, H1 2017

Anesthetic Effect-Pipeline by NanoMedex Pharmaceuticals Inc, H1 2017

Anesthetic Effect-Pipeline by Paion AG, H1 2017

Anesthetic Effect-Pipeline by Phosphagenics Ltd, H1 2017

Anesthetic Effect-Pipeline by Physica Pharma, H1 2017

Anesthetic Effect-Pipeline by Primex Pharmaceuticals Oy, H1 2017

Anesthetic Effect-Pipeline by Proteus SA, H1 2017

Anesthetic Effect-Pipeline by Sphaera Pharma Pvt Ltd, H1 2017

Anesthetic Effect-Pipeline by Taiwan Liposome Company Ltd, H1 2017

Anesthetic Effect-Pipeline by The Medicines Company, H1 2017

Anesthetic Effect-Pipeline by WEX Pharmaceuticals Inc, H1 2017

Anesthetic Effect-Dormant Projects, H1 2017

Anesthetic Effect-Discontinued Products, H1 2017

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

4P Therapeutics LLC, Biolab Farmaceutica Ltda, Drawbridge Pharmaceuticals Pty Ltd, Expanesthetics Inc, Jiangsu Hengrui Medicine Co Ltd, Lee's Pharmaceutical Holdings Ltd, Lipicard Technologies Ltd, NanoMedex Pharmaceuticals Inc, Paion AG, Phosphagenics Ltd, Physica Pharma, Primex Pharmaceuticals Oy, Proteus SA, Sphaera Pharma Pvt Ltd, Taiwan Liposome Company Ltd, The Medicines Company, WEX Pharmaceuticals Inc

select a license
Single User License
USD 2000 INR 144740
Site License
USD 4000 INR 289480
Corporate User License
USD 6000 INR 434220

NEWSLETTER BY CATEGORY




Testimonials

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com